tiprankstipranks
Evgen Pharma PLC (GB:TCF)
LSE:TCF

Evgen Pharma (TCF) Financial Statements

1 Followers

Evgen Pharma Financial Overview

Evgen Pharma's market cap is currently ―. The company's EPS TTM is p-0.011; its P/E ratio is -0.71; Evgen Pharma is scheduled to report earnings on December 4, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Mar 22Sep 21Mar 21Sep 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 7.17M£ 9.03M£ 10.05M£ 11.59M£ 2.31M
Total Assets£ 7.57M£ 9.64M£ 10.75M£ 12.42M£ 2.99M
Total Debt£ 0.00£ 0.00£ 0.00£ 0.00£ 0.00
Net Debt£ -7.17M£ -9.03M£ -10.05M£ -11.59M£ -2.31M
Total Liabilities£ 434.00K£ 411.00K£ 383.00K£ 607.00K£ 434.00K
Stockholders Equity£ 7.14M£ 9.23M£ 10.37M£ 11.81M£ 2.55M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Evgen Pharma Earnings and Revenue History

Evgen Pharma Debt to Assets

Evgen Pharma Cash Flow

Evgen Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis